Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
NuScale Power
SMR
$4.06B
| $25.8M | 0.01% |
1,817,923
+1,592,156
| +705% | +$45.5M |
|
1102
Snap
SNAP
$9.32B
| $25.7M | 0.01% |
3,189,679
+424,885
| +15% | +$3.36M |
|
|
NBIS
1103
Nebius Group N.V.
NBIS
$49.1B
| $25.7M | 0.01% |
307,444
+283,010
| +1,158% | +$29.3M |
|
1104
CleanSpark
CLSK
$2.96B
| $25.6M | 0.01% |
2,534,090
+496,421
| +24% | +$7.44M |
|
1105
Artisan Partners
APAM
$3.08B
| $25.6M | 0.01% |
629,430
+116,997
| +23% | +$4.99M |
|
1106
Fomento Económico Mexicano
FMX
$40.3B
| $25.6M | 0.01% |
253,350
+102,431
| +68% | +$9.95M |
|
1107
SEI Investments
SEIC
$12.6B
| $25.6M | 0.01% |
311,803
+156,400
| +101% | +$12.9M |
|
1108
Stanley Black & Decker
SWK
$15.7B
| $25.6M | 0.01% |
344,026
-82,083
| -19% | -$5.78M |
|
1109
PUT
ConocoPhillips
COP
$151B
| $25.5M | 0.01% |
272,300
+90,000
| +49% | +$8.14M |
|
|
SCHW
1110
CALL
Charles Schwab
SCHW
$186B
| $25.5M | 0.01% |
254,800
| – | – |
|
1111
The Mosaic Company
MOS
$7.34B
| $25.5M | 0.01% |
1,056,596
-550,013
| -34% | -$14.8M |
|
1112
CALL
Canadian Natural Resources
CNQ
$98.1B
| $25.4M | 0.01% |
750,000
| – | – |
|
|
PCI
1113
PGIM Corporate Bond 5-10 Year ETF
PCI
$527M
| $25.3M | 0.01% |
500,000
| – | – |
|
1114
Mueller Industries
MLI
$15.1B
| $25.3M | 0.01% |
441,410
-31,214
| -7% | -$1.68M |
|
|
OKLO
1115
CALL
Oklo
OKLO
$8.74B
| $25.3M | 0.01% |
+352,200
| New | +$39.3M |
|
1116
Franco-Nevada
FNV
$46.4B
| $25.3M | 0.01% |
121,922
+51,032
| +72% | +$10.3M |
|
1117
Sun Communities
SUI
$14.5B
| $25.3M | 0.01% |
203,893
+13,831
| +7% | +$1.73M |
|
1118
PUT
US Global Jets ETF
JETS
$827M
| $25.3M | 0.01% |
900,000
-1,450,000
| -62% | -$37.7M |
|
1119
Piper Sandler
PIPR
$5.35B
| $25.3M | 0.01% |
297,440
-54,764
| -16% | -$4.63M |
|
1120
Pinterest
PINS
$13.4B
| $25.2M | 0.01% |
972,832
+572,507
| +143% | +$16.5M |
|
1121
PUT
Estee Lauder
EL
$31.8B
| $25.1M | 0.01% |
240,100
-103,200
| -30% | -$10M |
|
1122
CALL
Alnylam Pharmaceuticals
ALNY
$29.6B
| $25.1M | 0.01% |
+63,000
| New | +$27.9M |
|
1123
Hancock Whitney
HWC
$6.28B
| $25M | 0.01% |
393,198
+118,923
| +43% | +$7.22M |
|
1124
Par Pacific Holdings
PARR
$3.78B
| $25M | 0.01% |
711,591
+5,759
| +0.8% | +$229K |
|
1125
MGIC Investment
MTG
$6.23B
| $25M | 0.01% |
855,087
-67,795
| -7% | -$1.9M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.